Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results GlobeNewswire Aug 6, 2024 10:30am
Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront Global News Select Oct 31, 2023 10:44am
Beam Therapeutics to reduce staff by 20% as it seeks to extend cash runway into 2026 MarketWatch Oct 19, 2023 12:56pm